India Glycols (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
India Glycols Limited |
|||
|
Price: ₹1,331.10 | ||
| 52 Week Low: ₹678.55 52 Week High: ₹1,548.95 |
|||
| Market Capital: 3,508.24 Crore (Smallcap) | |||
| Basic Materials -> Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: India Glycols Share Price Target For 2024
- 1.1.1: India Glycols Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: India Glycols Share Price Target For 2025
- 1.2.1: India Glycols Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: India Glycols Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: India Glycols Brief Company Overview
- 4: India Glycols Financial Performance
- 4.0.1: Is India Glycols A Good Buy For Long Term?
To predict the India Glycols's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
India Glycols Share Price Target For 2024
The line chart displays the monthly closing prices of India Glycols with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for India Glycols shares in 2024, see the table below.
India Glycols Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1405.05 (+5.55%) | Price Action: 17 Dec 2024 High |
| 2024 Target 2 | 1390.15 (+4.43%) | Price Action: Aug 2024 High |
| 2024 Target 1 | 1374.0 (+3.22%) | Price Action: 16 Dec 2024 Low |
| Current Price | 1331.10 | India Glycols's share price as of 20 Dec 2024 |
| Stop Loss 1 | 1308.44 (-1.71%) | Price Action: 23 Oct 2024 High |
| Stop Loss 2 | 1283.15 (-3.61%) | Price Action: 08 Nov 2024 High |
| Stop Loss 3 | 1266.93 (-4.83%) | Price Action: Jul 2024 High |
Short-Term Technical Outlook
Current Technical Position: India Glycols is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹1308.26 serves as the nearest technical reference point.
Historical Returns: 3-month: +8.40% | 6-month: +51.35% | 1-year: +74.44%
India Glycols Share Price Target For 2025
The line chart displays the monthly closing prices of India Glycols with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for India Glycols shares in 2025, see the table below.
India Glycols Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1956.05 (+46.94%) | Price Action: Chart |
| 2025 Target 2 | 1919.58 (+44.21%) | Price Action: Chart |
| 2025 Target 1 | 1900.57 (+42.78%) | Fibonacci Extension Level 64.90% |
| Current Price | 1331.10 | India Glycols's share price as of 20 Dec 2024 |
| Stop Loss 1 | 1198.8 (-9.94%) | Price Action: 05 Nov 2024 Low |
| Stop Loss 2 | 1186.0 (-10.91%) | Price Action: 04 Nov 2024 Low |
| Stop Loss 3 | 1170.0 (-12.11%) | Price Action: 25 Nov 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: India Glycols is currently trading at 75.0% of its 52-week range (₹678.55 - ₹1548.95).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +74.44% | 3-year: +50.16% | 5-year: +542.61%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
India Glycols Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,331.10 | ||
| 2024 | ₹1,206.24 | -9.38% | ₹1,224.33 |
| 2025 | ₹1,967.02 | +63.07% | ₹2,049.02 |
| 2026 | ₹2,934.92 | +49.21% | ₹2,978.94 |
| 2027 | ₹3,694.85 | +25.89% | ₹3,750.27 |
| 2028 | ₹3,807.80 | +3.06% | ₹3,864.92 |
| 2029 | ₹4,023.06 | +5.65% | ₹4,706.73 |
| 2030 | ₹5,098.08 | +26.72% | ₹5,592.63 |
| 2031 | ₹6,478.54 | +27.08% | ₹6,575.72 |
| 2032 | ₹7,288.26 | +12.50% | ₹7,397.58 |
| 2033 | ₹6,908.05 | -5.22% | ₹7,364.44 |
| 2034 | ₹6,839.88 | -0.99% | ₹8,250.35 |
| 2035 | ₹8,229.14 | +20.31% | ₹9,136.25 |
| 2036 | ₹10,022.15 | +21.79% | ₹10,172.48 |
| 2037 | ₹10,881.67 | +8.58% | ₹11,044.90 |
| 2038 | ₹10,008.29 | -8.03% | ₹10,158.41 |
| 2039 | ₹9,225.35 | -7.82% | ₹9,363.73 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
India Glycols Brief Company Overview
India Glycols Limited: A Green Petrochemical Powerhouse Established in 1983, India Glycols Limited is a notable green petrochemical company in India, renowned for its diverse product range, sustainability initiatives, and industry reputation. Key Products and Services: ...
Petrochemicals: Glycols, Polyethylene Glycols, Ethoxylates Potable Spirits: Whisky, Rum, Vodka Biopharmaceuticals: Active Pharmaceutical Ingredients, Nutraceuticals Performance Chemicals: Brake Fluids, Anti-Freeze Coolants India Glycols' commitment to sustainable practices and innovation has earned them recognition in the industry. Their diverse product portfolio caters to a wide array of sectors, including automotive, pharmaceutical, and personal care.India Glycols Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3,508.24 Crore | Market valuation of India Glycols's shares. |
| Revenue (TTM) | 3,760.2 Crore | Total revenue generated by India Glycols over the past twelve months. |
| Net Income (TTM) | +1,939,330,944.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +9.17% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +5.15% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+24.10% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+30.80% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
77.46 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,654.72 Crore | Sum of India Glycols's current & long-term financial obligations. |
| Total Cash | 103.15 Crore | Total amount of liquid funds available to India Glycols. |
| Beta | 0.47 | Beta is less than 1 indicating that the India Glycols's price is less volatile than the market. |
Is India Glycols A Good Buy For Long Term?
India Glycols (market cap: ₹3,508.24 crore), while showing strong revenue growth (₹3,760.2 crore TTM) and impressive past returns (69.83% in 12 months, 267.22% in 3 years), presents a mixed outlook. A significant debt of ₹1,654.72 crore (Q2 2024-25) against a relatively low cash balance (₹103.15 crore) raises concerns. The 5.15% profit margin is modest. Although recent quarterly revenue growth is positive (24.1%), the substantial debt needs careful consideration. Therefore, it's an average buy for the long term, warranting further in-depth analysis.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
